Pede Biotech has completed tens of millions of yuan in Series A financing.

On December 19, Chengdu Pide Biopharmaceutical Co., Ltd. announced the completion of tens of millions of yuan in Series A financing. This round of financing was exclusively invested by the Shanno Fund under Shenzhen Qianhai Shangshan Private Equity Investment Fund Management Co., Ltd. The funds raised will be used to advance the research and development of core pipelines for pain, cardiovascular, and respiratory diseases, while also deploying large-scale artificial intelligence-assisted peptide drug development technology.